Subscribe
Israel-Hamas Conflict
NFL
Kamala Harris
Donald Trump
US Economy
Floods
US Politics
Republican Party
Soccer
US Immigration
Fox News
Eric Adams
SEC
Published

FTC sues drug middlemen for allegedly inflating insulin prices

  • The Federal Trade Commission sued three largest pharmacy benefit managers for allegedly inflating insulin prices, boosting profits at patients' expense.
  • The lawsuit targets UnitedHealth Group's Optum Rx, CVS Health's Caremark, and Cigna's Express Scripts for anticompetitive practices.
  • The FTC aims to stop these practices and restore competition to help reduce drug prices for consumers.
Insights by Ground AI
Does this summary seem wrong?

0 Articles

All
Left
Center
Right
ReutersReuters

US FTC sues drug 'gatekeepers' over high insulin prices

The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of steering diabetic patients towards higher priced insulin in order to reap millions of dollars in rebates from pharmaceutical companies.

·United Kingdom
Read Full Article
Associated Press NewsAssociated Press News

High insulin prices spur a federal lawsuit against three pharmacy benefit managers

The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin soar for diabetic patients.

·United States
Read Full Article
abc Newsabc News

High insulin prices spur a federal lawsuit against three pharmacy benefit managers

The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin soar for patients

·United States
Read Full Article
CNNCNN

Federal Trade Commission sues largest drug middlemen for allegedly inflating insulin prices

The Federal Trade Commission alleges CVS Health’s Caremark Rx, Cigna’s Express Scripts and United Health Group’s OptumRx created a system that prioritizes high rebates from drug manufacturers, leading to artificially high insulin list prices.

·Atlanta, United States
Read Full Article
KIFIKIFI

Federal Trade Commission sues largest drug middlemen for allegedly inflating insulin prices

By Tami Luhby, CNN (CNN) — The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that resulted in patients paying more the medications. The agency alleges that CVS Health’s Caremark Rx, Cigna’s Express Scripts and United Health Group’s OptumRx and their affiliated group purchasing organizations created a system that prioritizes hig…

·Idaho Falls, United States
Read Full Article
KRDOKRDO

Federal Trade Commission sues largest drug middlemen for allegedly inflating insulin prices

By Tami Luhby, CNN (CNN) — The Federal Trade Commission took action Friday against the nation’s three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that resulted in patients paying more for the medications. The agency alleges that CVS Health’s Caremark Rx, Cigna’s Express Scripts and UnitedHealth Group’s Optum Rx and their affiliated group purchasing organizations created a system that pr…

·Colorado Springs, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 73% of the sources are Center
72% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics

DiabetesDiabetes
FTCFTC
UnitedHealthUnitedHealth
CignaCigna
PoliticsPolitics
US PoliticsUS Politics
HealthHealth
Trending Topics
Ground News logo
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc
News
For You
Search
BlindspotLocal